These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27116264)

  • 1. Improving access to NCD medicines through collaboration.
    Chan K; Mandeville KL
    Lancet; 2016 Apr; 387(10029):1704-5. PubMed ID: 27116264
    [No Abstract]   [Full Text] [Related]  

  • 2. The Health Impact Fund: incentives for improving access to medicines.
    Banerjee A; Hollis A; Pogge T
    Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
    [No Abstract]   [Full Text] [Related]  

  • 3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 4. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 5. A landmark report on improving medicines for children.
    't Jong GW; Klassen TP; MacLeod SM
    JAMA Pediatr; 2015 Mar; 169(3):204-5. PubMed ID: 25561323
    [No Abstract]   [Full Text] [Related]  

  • 6. Access to medicines in Senegal: results of a sample survey.
    Garenne M; Candau D; Guimier JM; Badiane M; Diop AC; Teulières LC
    Trop Doct; 2006 Jan; 36(1):5-8. PubMed ID: 16483417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to medicines report cards.
    Mullard A
    Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336
    [No Abstract]   [Full Text] [Related]  

  • 8. How the MDGs gave up on measuring access to medicines.
    Gotham D; Onarheim KH; Barber MJ
    Lancet Glob Health; 2016 May; 4(5):e296-7. PubMed ID: 27102189
    [No Abstract]   [Full Text] [Related]  

  • 9. The great medicines scandal: access is not just about cost.
    Waning BJ
    BMJ; 2006 Jul; 333(7557):44. PubMed ID: 16809717
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to AIDS medicines stumbles on trade rules.
    Wise J
    Bull World Health Organ; 2006 May; 84(5):342-4. PubMed ID: 16710536
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines.
    Ruxin J; Paluzzi JE; Wilson PA; Tozan Yi; Kruk M; Teklehaimanot A
    Lancet; 2005 Feb 12-18; 365(9459):618-21. PubMed ID: 15708108
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving availability and affordability of plasma-derived medicines.
    Cheraghali AM; Abolghasemi H
    Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research to support pharmaceutical policies].
    Wirtz VJ; Reich MR; Hernández-Avila M
    Salud Publica Mex; 2008; 50 Suppl 4():S427-8. PubMed ID: 19082252
    [No Abstract]   [Full Text] [Related]  

  • 14. The concept of essential medicines: lessons for rich countries.
    Hogerzeil HV
    BMJ; 2004 Nov; 329(7475):1169-72. PubMed ID: 15539676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential drugs should be accessible to all people.
    Habiyambere V; Wertheimer AI
    World Health Forum; 1993; 14(2):140-4. PubMed ID: 8185754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alliance aims to help health workers in poor countries challenge corruption, excessive pricing, and waste of drugs.
    Moszynski P
    BMJ; 2008 May; 336(7654):1155. PubMed ID: 18497408
    [No Abstract]   [Full Text] [Related]  

  • 17. The great medicines scandal: next steps?
    Kaplan WA
    BMJ; 2006 Jul; 333(7557):44-5. PubMed ID: 16809716
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving Global Access to State of the Art Practice Information.
    Gilada TI; Baheti AD; Green DE
    J Am Coll Radiol; 2016 Sep; 13(9):1156-7. PubMed ID: 27451117
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of medicines in Mexico.
    Agren D
    Lancet; 2021 Jul; 398(10297):289-290. PubMed ID: 34303425
    [No Abstract]   [Full Text] [Related]  

  • 20. The Effects of Intellectual Property Rights on Access to Medicines and Catastrophic Expenditure.
    Jung Y; Kwon S
    Int J Health Serv; 2015; 45(3):507-29. PubMed ID: 26077858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.